
Global Dry Eye Treatment Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
-
17217
-
Feb 2022
-
154
-
PDF
-
-
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
-
“Global Dry Eye Treatment Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in to various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global dry eye treatment market has been segmented on the basis of technology, as well as regions and countries.
Overview:
Dry eye disease is a common condition that occurs when your tears aren’t able to provide adequate lubrication for your eyes. Tears can be adequate and unstable for many reasons. For example, dry eyes may occur if an individual doesn’t produce enough tears or if that individual produces poor-quality tears.
Dynamics:
The growing demand for quicker, non-invasive approaches to dry eye treatment that offer long-term relief to individuals is major factor that is expected to continue to fuel the revenue growth of the global dry eye treatment market over the next 10 years. Moreover, eye care providers are now more inclined to address the primary cause of this disease, as opposed to merely offering temporary relief solutions. This is also a factor that is slated to positively contribute to the market growth of this global industry in the near future.
In light of the recent COVID-19 outbreak, the operations of numerous industries have been either temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global dry eye treatment industry is no different, and this factor is expected to negatively impact on market growth in the years to come. Furthermore, the availability of alternative forms of treatment, the high costs associated with laser treatment, as well as the lack of efficient health insurance policy coverages in various countries, are some of the factors that are anticipated to restrain the revenue growth of the global dry eye treatment market in the coming years.
Nonetheless, the increasing prevalence of dry eye disease as a result of varying elements such as the over-usage of contact lenses, glaucoma, diabetes, as well as the prolonged exposure to digital screens are some of the factors that are expected to continue to augment further revenue growth of the global dry eye treatment market in the foreseeable future.
Segmentation of the global dry eye treatment market is as follows:
In terms of technology, the Meibomian Gland Expression (MGX) segment accounted for the maximum number of revenue shares of the global dry eye treatment market in 2020, and is indicative of indexing a high CAGR in the years to come. This can be attributed to MGX being an efficient option of treatment for Meibomian Gland Dysfunction (MGD), a leading cause of dry eye disease. Moreover, new technologically advanced product launches are anticipated to further compliment the future expansion of this segment. The Intense Pulsed Light (IPL) segment is also expected to index considerable revenue growth in the years to come. The combination (IPL+MGX) segment is anticipated to register the highest CAGR over the forecast period.
Regional Segmentation and Analysis:
North America accounted for the highest number of revenue shares of the global dry eye treatment market in 2020, and is slated to register a considerable CAGR over the forecast period. This can be attributed to the increasing prevalence of dry eye disease, as well as increasing healthcare expenditures in this region. The market in Europe are expected to register considerable revenue growth in the coming years. However, the markets in the Asia Pacific region are slated to index the fastest rate of revenue growth in the next decade owing to the presence of a large patient pool, as well as improving healthcare infrastructures in this region.
Segmentation of the Global Dry Eye Treatment Market:
Segmentation by Technology:
- Broadband light (BBL)
- Intense Pulsed Light (IPL)
- Meibomian Gland Expression (MGX)
- Combination (MGX+IPL)
Segmentation by Regions:
- North America
- Europe
- APAC
- South America
- MEA
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
- MiBo Medical Group
- Alcon
- Sight Sciences
-
Request for TOC
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!